Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections

Background: The novel coronavirus (SARS-CoV-2) shares approximately 80% whole genome sequence identity and 66% spike (S) protein identity with that of SARS-CoV. The cross-neutralization between these viruses is currently not well-defined. Methods: Here, by using the live SARS-CoV-2 virus infection a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ren Yang, Jiaming Lan, Baoying Huang, Ruhan A, Mingqing Lu, Wen Wang, Wenling Wang, Wenhui Li, Yao Deng, Gary Wong, Wenjie Tan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2020-08-01
coleção:	EBioMedicine
Assuntos:	COVID-19 SARS-CoV-2 CoV Cross-neutralization ACE2
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2352396420302656
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!